InvestSMART

Pilbara Gold Limited (ASX: PGL) - Announcements

Current share price for PGL : $0.520 0.01 (1.96%)+

ASX company news and announcements for Pilbara Gold Limited (PGL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pilbara Gold Limited (PGL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pilbara Gold Limited (PGL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pilbara Gold Limited (PGL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$122 Lodgement of Supplementary Prospectus 24 Nov 2015 3:58PM $0.220 $0.520 risen by 136.36%
$122 Extension of Exposure Period 18 Nov 2015 8:25AM $0.200 $0.520 risen by 160%
$122 Amended Announcement - Lodgement of Prospectus and App 3B 11 Nov 2015 1:07PM $0.220 $0.520 risen by 136.36%
$122 Lodgement of Prospectus and Appendix 3B 11 Nov 2015 11:49AM $0.220 $0.520 risen by 136.36%
$122 2015 AGM & General Meeting Documentation 4 Nov 2015 5:45PM $0.220 $0.520 risen by 136.36%
$122 2015 Form 20-F Filed with the US SEC 2 Nov 2015 11:33AM $0.190 $0.520 risen by 173.68%
$122 TBG Acquisition - Updated Independent Expert's Report 2 Nov 2015 9:13AM $0.190 $0.520 risen by 173.68%
$122 Update - TBG Acquisition & Dates of AGM and General Meeting 2 Nov 2015 9:12AM $0.190 $0.520 risen by 173.68%
$122 TBG Acquisition - Independent Expert's Report 19 Oct 2015 10:14AM $0.165 $0.520 risen by 215.15%
$122 Progen to Proceed with Strategic Acquisition of TBG Inc. 16 Oct 2015 3:00PM $0.165 $0.520 risen by 215.15%
$122 Corporate Governance Statement & Appendix 4G 30 Sep 2015 4:13PM $0.165 $0.520 risen by 215.15%
$122 Annual Report to shareholders 30 Sep 2015 8:33AM $0.150 $0.520 risen by 246.67%
$122 Preliminary Final Report 24 Aug 2015 4:31PM $0.150 $0.520 risen by 246.67%
$122 Initial & Final Directors' Interest Notices 6 Aug 2015 4:31PM $0.205 $0.520 risen by 153.66%
$122 Proposed Acquisition of TBG Inc and Strategic Review 1 May 2015 9:34AM $0.195 $0.520 risen by 166.67%
$122 Lapse of Unlisted Options Under ESOP 29 Apr 2015 8:24AM $0.200 $0.520 risen by 160%
$122 Half Yearly Report & Accounts 27 Feb 2015 12:29PM n/a $0.520 n/a
$122 Receipt of R&D Tax Incentive Refund 17 Feb 2015 11:10AM $0.165 $0.520 risen by 215.15%
$122 PI-88 Clinical Trial Update 28 Jan 2015 8:24AM n/a $0.520 n/a
$122 PG545 Phase 1 Trial Successfully Completes Third Cohort 19 Dec 2014 8:26AM $0.180 $0.520 risen by 188.89%
$122 Notice of Allowance of Canada Patent for PG545 14 Nov 2014 3:36PM $0.170 $0.520 risen by 205.88%
$122 PG545 Phase 1 Clinical Trial Update 22 Sep 2014 9:04AM $0.260 $0.520 risen by 100%
$122 Preliminary Final Report 26 Aug 2014 8:26AM $0.225 $0.520 risen by 131.11%
$122 Update to Interim Phase III Results for PI-88 29 Jul 2014 5:24PM $0.230 $0.520 risen by 126.09%
$122 Interim Phase III Results for PI-88 28 Jul 2014 8:53AM $0.295 $0.520 risen by 76.27%

401 - 425 of 578 results

Page 17 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.